Standardisation of molecular monitoring for chronic myeloid leukaemia
Keywords: حداقل بیماری باقی مانده; BCR-ABL; real time PCR; international scale; minimal residual disease
مقالات ISI حداقل بیماری باقی مانده (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Role of Minimal Residual Disease Monitoring in Adult and Pediatric Acute Lymphoblastic Leukemia
Keywords: حداقل بیماری باقی مانده; Acute lymphoblastic leukemia; Minimal residual disease; Flow cytometry; Polymerase chain reaction; Prognosis
Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults
Keywords: حداقل بیماری باقی مانده; Acute lymphoblastic leukemia; Graft versus leukemia; Minimal residual disease; Philadelphia chromosome positive ALL; Precursor B cell ALL; Precursor T cell ALL; Total body irradiation; Reduced intensity transplant
Molecular Diagnosis of Hematopoietic and Lymphoid Neoplasms
Keywords: حداقل بیماری باقی مانده; Gene rearrangements; Clonality; Chromosome translocation; Polymerase chain reaction; Fluorescence in situ hybridization; Minimal residual disease;
Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate
Keywords: حداقل بیماری باقی مانده; Chronic myeloid leukemia; Interferon alpha; Imatinib; Minimal residual disease
PRAME expression in hairy cell leukemia
Keywords: حداقل بیماری باقی مانده; Hairy cell leukemia; Real-time PCR; Chronic lymphocytic leukemia; PRAME; TaqMan; Minimal residual disease
WT1 protein expression in slowly proliferating myeloid leukemic cell lines is scarce throughout the cell cycle with a minimum in G0/G1 phase
Keywords: حداقل بیماری باقی مانده; Wilms’ tumor gene 1 (WT1); Acute leukemia; Minimal residual disease; Immunotherapy; Leukemic stem cells
Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML)
Keywords: حداقل بیماری باقی مانده; hematopoietic cell transplantation; acute myeloid leukemia; minimal residual disease; chemotherapy; PCR-based assays; multicolor flow cytometry
Autologous Stem Cell Transplantation with PCR-Negative Graft Would Be Associated with a Favorable Outcome in Core-Binding Factor Acute Myeloid Leukemia
Keywords: حداقل بیماری باقی مانده; Core binding factor acute myeloid leukemia; Autologous stem cell transplantation; Minimal residual disease; Polymerase chain reaction;
Bone marrow micrometastases in different solid tumors: Pathogenesis and importance
Keywords: حداقل بیماری باقی مانده; Micrometastasis; Disseminated tumor cells; Minimal residual disease; Bone marrow; Prognosis
DRAQ5: Improved flow cytometric DNA content analysis and minimal residual disease detection in childhood malignancies
Keywords: حداقل بیماری باقی مانده; DRAQ5; DNA content analysis; Flow cytometry; Minimal residual disease; Neuroblastoma; Acute lymphoblastic leukemia
Integrating molecular information into treatment of childhood acute lymphoblastic leukemia—A perspective from the BFM Study Group
Keywords: حداقل بیماری باقی مانده; Acute lymphoblastic leukemia; Childhood; Prognostic factors; Treatment response; Prednisone response; Minimal residual disease; Gene expression profiling; Genetic variation
PRAME mRNA levels in cases with chronic leukemia: Clinical importance and review of the literature
Keywords: حداقل بیماری باقی مانده; Chronic leukemia; PRAME; Minimal residual disease; Immunotherapy
Frequency and prognostic significance of occult tumor cells in lymph nodes in patients with adenocarcinoma of the papilla of Vater
Keywords: حداقل بیماری باقی مانده; micrometastasis; lymph nodes; carcinoma of the papilla of Vater; minimal residual disease; immunohistochemistry;
I17 Treatment of acute lymphoblastic leukemia in adults
Keywords: حداقل بیماری باقی مانده; Acute lymphoblastic leukemia; Molecular targeting; Antibody therapy; Ph/bcrabl ALL; Minimal residual disease; Prognostic factors; Stem cell transplantation;
Increased midkine gene expression in childhood B-precursor acute lymphoblastic leukemia
Keywords: حداقل بیماری باقی مانده; Midkine; Acute leukemia; Children; Prognostic factor; Minimal residual disease; Real-time PCR; WT1;
Prevention of tumor recurrence and distant metastasis formation in a breast cancer mouse model by biodegradable implant of 131I-norcholesterol
Keywords: حداقل بیماری باقی مانده; Crosslinked chitosan; Biodegradable implant; Brachytherapy; Breast cancer; Locoregional recurrence; Minimal residual disease
Comparison of minimal residual disease (MRD) estimated by flow cytometry and by real-time quantitative PCR of Wilms tumor gene 1 (WT1) transcript expression in children with acute lymphoblastic leukemia
Keywords: حداقل بیماری باقی مانده; Minimal residual disease; Acute lymphoblastic leukemia; Flow cytometry; Wilms tumor gene 1; Real-time quantitative PCR
In vivo bioluminescence imaging for early detection and monitoring of disease progression in a murine model of neuroblastoma
Keywords: حداقل بیماری باقی مانده; Bioluminescence imaging; Neuroblastoma; Minimal residual disease
Maintenance therapy in cutaneous T-cell lymphoma: Who, when, what?
Keywords: حداقل بیماری باقی مانده; T-cell lymphoma, cutaneous; Combined modality therapy; Remission induction; Minimal residual disease; Mycosis fungoides; Progression-free survival; Quality of life; Sézary syndrome; Treatment efficacy
Revision of the guidelines for diagnosis and therapy of chronic lymphocytic leukemia (CLL)
Keywords: حداقل بیماری باقی مانده; chronic lymphocytic leukemia; guidelines; diagnosis; prognosis; response criteria; minimal residual disease
Hematopoietic Stem Cell Recipients Do Not Develop Post-transplantation Immune Tolerance to Antigens Present on Minimal Residual Disease
Keywords: حداقل بیماری باقی مانده; graft versus leukemia effect; tumor vaccine; minimal residual disease; tolerance; minor histocompatibility antigen
Minimal residual disease assessment in chronic lymphocytic leukaemia
Keywords: حداقل بیماری باقی مانده; chronic lymphocytic leukaemia; minimal residual disease
A multimarker real-time RT-PCR for MAGE-A gene expression allows sensitive detection and quantification of the minimal systemic tumor load in patients with localized cancer
Keywords: حداقل بیماری باقی مانده; Minimal residual disease; MAGE-A expression; RT-PCR; Real-time PCR
WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder
Keywords: حداقل بیماری باقی مانده; Down syndrome; Transient myeloproliferative disorder; WT1; Minimal residual disease
Use of simplified strategies to evaluate early treatment response in childhood acute lymphoblastic leukemia
Keywords: حداقل بیماری باقی مانده; Minimal residual disease; Early treatment response; ALL
Assessment of a new RNA stabilizing reagent (Tempus Blood RNA) for minimal residual disease in onco-hematology using the EAC protocol
Keywords: حداقل بیماری باقی مانده; RNA stabilization in blood; Myeloproliferative disorders; Acute lymphoblastic leukemia; BCR-ABL; Real time quantitative PCR; Minimal residual disease
Minimal residual core binding factor AMLs by real time quantitative PCR—Initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood unravels the kinetics of relapse
Keywords: حداقل بیماری باقی مانده; Core binding factor leukaemia; Minimal residual disease; Real time quantitative PCR; Leukemogenesis
Pattern of immunoglobulin and T-cell receptor (Ig/TCR) gene rearrangements in Polish pediatric acute lymphoblastic leukemia patients—implications for RQ-PCR-based assessment of minimal residual disease
Keywords: حداقل بیماری باقی مانده; ALL; Ig gene rearrangements; TCR gene rearrangements; Minimal residual disease
Rituximab Induces Effective Clearance of Minimal Residual Disease in Molecular Relapses of Mantle Cell Lymphoma
Keywords: حداقل بیماری باقی مانده; Mantle cell lymphoma; Minimal residual disease; Molecular remission; Monoclonal antibodies; Maintenance therapy
Therapeutic and Diagnostic Applications of Minor Histocompatibility Antigen HA-1 and HA-2 Disparities in Allogeneic Hematopoietic Stem Cell Transplantation: A Survey of Different Populations
Keywords: حداقل بیماری باقی مانده; Minor histocompatibility antigens HA-1 and HA-2; Hematopoietic stem cell transplantation; Minimal residual disease; Host chimerism; Graft-versus-leukemia activity; Population study
NF-κB and COX-2 during oral tumorigenesis and in assessment of minimal residual disease in surgical margins
Keywords: حداقل بیماری باقی مانده; Minimal residual disease; Oral cancer; NF-κB; COX-2
Surgical excision combined with autologous whole tumor cell vaccination is an effective therapy for murine neuroblastoma
Keywords: حداقل بیماری باقی مانده; Immunostimulatory DNA; CpG; Oligodeoxynucleotide; GM-CSF; Immunotherapy; Neuroblastoma; Tumor vaccine; Minimal residual disease
Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia: When Should It Be Used?
Keywords: حداقل بیماری باقی مانده; ara-C; cytarabine; AP; accelerated phase; BC; blast crisis; CCR; complete cytogenetic response; CML; chronic myelogenous leukemia; GVHD; graft-vs-host disease; IRIS; International Randomised Study of Interferon versus STI571; MCR; major cytogenetic respon
Chronic Lymphocytic Leukemia: Diagnosis and Treatment
Keywords: حداقل بیماری باقی مانده; AIHA; autoimmune hemolytic anemia; AML; acute myeloid leukemia; CALGB; Cancer and Leukemia Group B; CAP; cyclophosphamide, doxorubicin (Adriamycin), and prednisone; CHOP; cyclophosphamide, hydroxydaunomycin (doxorubicin), vincristine (Oncovin) and prednis
Wilms' tumor 1 (WT1) gene in hematopoiesis: a surrogate marker of cell proliferation as a possible mechanism of action?
Keywords: حداقل بیماری باقی مانده; hematopoiesis; leukemia; minimal residual disease; WT1 gene;
Leucemia mÃnima residual: nuevo concepto de remisión completa
Keywords: حداقل بیماری باقی مانده; Leucemia linfoblástica aguda; Enfermedad mÃnima residual; CitometrÃa de flujo; Remisión completa; Acute lymphoblastic leukemia; Minimal residual disease; Flow cytometry; Complete remission;
Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation
Keywords: حداقل بیماری باقی مانده; Non-myeloablative transplantation; Minimal residual disease; Chimerism;
Evaluation and Automation of Hematopoietic Chimerism Analysis Based on Real-Time Quantitative Polymerase Chain Reaction
Keywords: حداقل بیماری باقی مانده; Transplantation chimera; Hematopoietic stem cell transplantation; Polymerase chain reaction; Polymorphism; Minimal residual disease;
Employing the immunological synapse in AML: Development of leukemic dendritic cells for active specific immunization
Keywords: حداقل بیماری باقی مانده; Acute myeloid leukaemia; Dendritic cells; Immunological synapse; Immunotherapy; AML; acute myeloid leukemia; CLIP; class II-associated invariant chain peptide; c-SMAC; central-supramolecular activating complex; IS; immunological synapse; MRD; minimal resi
IL-2-activated cord blood mononuclear cells
Keywords: حداقل بیماری باقی مانده; anti-tumor activity; cord blood; cytotoxic cells; IL-2; immunotherapy; minimal residual disease;
Specific detection of Flt3 point mutations by highly sensitive real-time polymerase chain reaction in acute myeloid leukemia
Keywords: حداقل بیماری باقی مانده; AML; acute myeloid leukemia; FL; Flt3 ligand; Flt3; class III receptor tyrosine kinase; Flt3-TKD; tyrosine kinase domain of Flt3; FRET; fluorescence resonance energy transfer; MRD; minimal residual disease; PBSCT; peripheral blood stem cell transplantatio
Adult Acute Lymphoblastic Leukemia
Keywords: حداقل بیماری باقی مانده; ALL; acute lymphoblastic leukemia; CALGB; Cancer and Leukemia Group B; CNS; central nervous system; CR; complete remission; CSF; cerebrospinal fluid; DFS; disease-free survival; EFS; event-free survival; G-CSF; granulocyte colony-stimulating factor; HIV;
Detecting minimal residual disease in neuroblastoma patients-the present state of the art
Keywords: حداقل بیماری باقی مانده; Neuroblastoma; Minimal residual disease; Review;
Chronic Myeloid Leukemia: Current Application of Cytogenetics and Molecular Testing for Diagnosis and Treatment
Keywords: حداقل بیماری باقی مانده; AHSCT; allogeneic hematopoietic stem cell transplantation; AP; advanced phase; ATP; adenosine triphosphate; CCR; complete cytogenetic remission; CML; chronic myeloid leukemia; CP; chronic phase; FISH; fluorescence in situ hybridization; M-bcr; major break
The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis
Keywords: حداقل بیماری باقی مانده; ABL; acute biphenotypic leukaemia; AF4; ALL1 fused gene from chromosome 4; AF9; ALL1 fused gene from chromosome 9; AF10; ALL1 fused gene from chromosome 10; ALL; acute lymphoblastic leukaemia; AML; acute myelogenous leukaemia; BM; bone marrow; BMT; bone m
Chronic Lymphoid Leukemias Other Than Chronic Lymphocytic Leukemia: Diagnosis and Treatment
Keywords: حداقل بیماری باقی مانده; ATL; adult T-cell leukemia; B-PLL; B-cell prolymphocytic leukemia; CLL; chronic lymphocytic leukemia; CR; complete response; CSF; colony-stimulating factor; FasL; Fas ligand; GC; germinal center; HCL; hairy cell leukemia; HTLV; human T-lymphotrophic virus
Quantitative flow cytometry in the clinical laboratory
Keywords: حداقل بیماری باقی مانده; ABC; antibody binding capacity; ALL; acute lymphocytic leukemia; CLL; chronic lymphocytic leukemia; MFI; mean fluorescence intensity; FITC; fluorescein isothiocyanate; FIS; fluorescence intensity standards; F:P; fluorochrome to protein ratio; GVHD; graft
Monitoring of minimal residual disease in acute myeloid leukemia
Keywords: حداقل بیماری باقی مانده; Minimal residual disease; Acute myeloid leukemia; Multiparameter flow cytometry;
What is remission in follicular lymphoma and what is its relevance?
Keywords: حداقل بیماری باقی مانده; follicular lymphoma; minimal residual disease; PCR; t(14;18);